GFM
FHTX icon

GF Fund Management’s Foghorn Therapeutics FHTX Stock Holding History

GF Fund Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.04K Buy
1,263
+152
+14% +$834 ﹤0.01% 596
2025
Q4 		$6K Sell
1,111
-81
-7% -$367 ﹤0.01% 614
2025
Q3 		$5.83K Sell
1,192
-232
-16% -$1.23K ﹤0.01% 602
2025
Q2 		$6.69K Hold
1,424
– – ﹤0.01% 609
2025
Q1 		$5.2K Buy
1,424
+257
+22% +$1.17K ﹤0.01% 622
2024
Q4 		$5.51K Buy
+1,167
New +$8.5K ﹤0.01% 606

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

GF Fund Management's FHTX Position: Q1 2026 in Review

GF Fund Management increased its Foghorn Therapeutics (FHTX) stake by 14% in Q1 2026, buying an estimated $834 and bringing the position to 1,263 shares worth $6.04K. The position accounts for ﹤0.01% of the portfolio, ranked #596.

GF Fund Management first reported a position in FHTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.69K in Q2 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • GF Fund Management held 1,263 shares of Foghorn Therapeutics worth $6.04K as of Q1 2026.
  • GF Fund Management bought 152 Foghorn Therapeutics shares in Q1 2026, an estimated $834.
  • Foghorn Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #596 holding.
  • GF Fund Management first reported a position in Foghorn Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Foghorn Therapeutics position peaked at $6.69K in Q2 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.